Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260423069139N1Phase 3Recruiting
Phase 3, randomised, single-blind trial in endometrial polyp comparing Dydrogesterone with Oral contraceptive pill control (2 arms). Primary endpoint: Endometrial polyp size. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260423069139N1.